Health Catalyst, Inc. (NASDAQ:HCAT), a prominent figure in the healthcare technology sector, is set to showcase its data and analytics solutions at several investor conferences. The company's senior management, including CEO Dan Burton, will discuss Health Catalyst's strategies and performance across these events.
The team is scheduled to attend the Stephens Annual Investment Conference in Nashville on November 19, 2025, featuring a fireside chat. Additionally, they will be present at the Canaccord Genuity MedTech, Diagnostics and Digital Health and Services Forum in New York on November 20, 2025, offering one-on-one meetings. The participation extends to the 8th Annual Evercore Healthcare Conference in Miami on December 2, 2025, and Citi's 2025 Global Healthcare Conference in Miami on December 3, 2025.
Central to Health Catalyst's operations is its cloud-based technology, Health Catalyst Ignite, which employs AI-enabled data and analytics to improve clinical, financial, and operational outcomes. The platform supports over 1,100 organizations worldwide, delivering billions in measurable results by transforming complex data into actionable insights.
In its recent financial performance, HCAT reported earnings per share of $0.06, surpassing the estimated $0.05. The company achieved a revenue of $76.32 million, exceeding the estimated $73.97 million. The company demonstrates efficiency with an asset turnover ratio of 0.51.
For the most recent quarter, HCAT reported a revenue of $76.32 million, with a cost of revenue of $38.51 million. Operating expenses were $55.33 million, resulting in a gross profit of $37.82 million. The net value of property, plant, and equipment stands at $39.87 million, reflecting the company's investment in its infrastructure.
